ClearNote Health secures $52 million to scale early cancer detection and expand global clinical and commercial operations.
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
The study, titled ‘Multiple instance learning approach for automated gallbladder cancer detection using ultrasound imaging: ...
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 2026 Jefferies Global ...
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Goldman Sachs 47th Annual ...
Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results